← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2010Last known activity
Dec 31, 2025
Timeline
2000s
- Jun 1, 2004
Molecular Partners AG— Founded
Drugs by trial phase (15 distinct, 15 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (10 own, 0 via acquisition)
Indications
Recent trials (15)
- NCT07278479Lead sponsorPhase 1/Phase 2Dec 31, 2025
- NCT07036380CollaboratorPhase 2Jun 30, 2025
- NCT05673057Lead sponsorPhase 1/Phase 2Dec 29, 2022
- NCT05098405Lead sponsorPhase 1Oct 11, 2021
- NCT05780463CollaboratorPhase 3Jun 11, 2021
- NCT04828161CollaboratorPhase 2/Phase 3May 24, 2021
- NCT04834856Lead sponsorPhase 2Apr 1, 2021
- NCT04870164Lead sponsorPhase 1Nov 18, 2020
- NCT04049903Lead sponsorPhase 1Aug 31, 2019
- NCT03418532Lead sponsorPhase 1/Phase 2Mar 1, 2018
- NCT03084926Lead sponsorPhase 1Jun 15, 2017
- NCT03136653Lead sponsorPhase 1/Phase 2May 23, 2017
- NCT02194426Lead sponsorPhase 1/Phase 2Jul 1, 2014
- NCT01086761CollaboratorPhase 1Mar 1, 2010
- NCT01042678CollaboratorPhase 1Feb 1, 2010
Details
- Founded
- Zurich, CH Jun 1, 2004
- Last known activity
- Dec 31, 2025